OCEA: Ocean Biomedical, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 61.85
Enterprise Value ($M) 78.98
Book Value ($M) -75.22
Book Value / Share -2.17
Price / Book -0.82
NCAV ($M) -75.22
NCAV / Share -2.17
Price / NCAV -0.82

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -3.95
Return on Equity (ROE) -63.86

Liquidity (mrq)
Quick Ratio 0.03
Current Ratio 0.03

Balance Sheet (mrq) ($M)
Current Assets 1.03
Assets 1.03
Liabilities 76.25
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Ayrton Capital LLC 9.90
02-13 13G/A Boothbay Fund Management, Llc 0.00
02-13 13G/A Atw Spac Management Llc 0.00
02-09 13G/A Polar Asset Management Partners Inc. 7.70
01-26 13G/A Weiss Asset Management LP 0.00
2023-03-24 13D/A Aesther Healthcare Sponsor, LLC 6.70 -71.77

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 63,630 44,816 141.98
2024-04-17 62,103 160,620 38.66
2024-04-16 49,836 232,957 21.39
2024-04-15 87,448 349,038 25.05

(click for more detail)

Similar Companies
NRXP – NRx Pharmaceuticals, Inc. NTBL – Notable Labs, Ltd.
NVCT – Nuvectis Pharma, Inc. OCGN – Ocugen, Inc.
OCUP – Ocuphire Pharma, Inc.


Financial data and stock pages provided by
Fintel.io